Immunitybio Inc NASDAQ:IBRX:
START SELLING WITH BigBCC TODAY
Start your free trial with BigBCC today.
BLOG | Global Expansion
Immunitybio Strengthens Balance Sheet With $100 Million Of Financing Transactions Including $75 Million Of Non-Dilutive Financing To Support Global Expansion And Advancement Of Broader Immunotherapy Pipeline







